Based on most current research regarding the more widespread use of class IC antiarrhythmic drugs, what are your prescribing practices in patients with coronary artery disease?
How do you approach prescribing class IC antiarrhythmic drugs in patients over 50 years old with potential coronary artery disease, given the risks highlighted in recent research?
Join Mednetto vote and see how they answered.
Fair question, as we know the definition of "structural heart disease" is unknown. In the trial, it was likely ischemia driving the poor outcomes, so I will get stress with imaging on everyone >50 years old (CAD risk). Given the common finding of "questionable" stent placement in the community, I wi...
Join for free or sign in to see the full answer
I will continue to do ischemic evaluation for my patients I consider for 1C agents.
Join for free or sign in to see the full answer
Since we have expertise in cardiac PET-CT locally, I certainly stress these patients in consultation with my electrophysiology team. If cardiac PET-CT is not available (e.g., outreach), I lean on EP since NM-SPECT is not as robust in terms of info on coronary physiology.
Join for free or sign in to see the full answer